De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Urban Lithium Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kwang-Bin Im

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

CEO

Kwang-Bin Im (60 yo)

no data

Tenure

Im Kwang-Bin served as the Chief Executive Officer of PMG Pharmascience Co., Ltd. (formerly known as AT technology Co., Ltd.) Lim Kwang-Bin serves as Representative Director of PMG Pharmascience Co., Ltd....

Urban Lithium Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Market cap size

New minor risk - Market cap size

Less than half of directors are independent

WI Co., Ltd. announced that it has received KRW 40.55 billion in funding from Lithium Insight Inc., Eleanor & K Co., Ltd.

WI Co., Ltd. announced that it expects to receive KRW 35 billion in funding

Less than half of directors are independent

PMG Pharmascience Co., Ltd. announced that it has received KRW 15 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd.

PMG Pharmascience Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Eugene Investment & Securities Co.,Ltd., JJ Assets Co., Ltd., Mirae Asset Securities Co., Ltd., JW Holdings Corporation, Kiwoom Securities Co., Ltd. and other investors

New 90-day low: ₩1,245

New 90-day low: ₩1,330

New 90-day low: ₩1,360

New 90-day high: ₩1,810

CEO

Tenure